Prs50 - Cost-Effectiveness Analysis of Surfactant Therapy for the Treatment of Respiratory Distress Syndrome Newborn in the Russian Federation

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.2444

Full Text

Abstract

Available in

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood

English

Respiratory Distress Syndrome of the Newborn--Principles in Treatment

Archives of Disease in Childhood

English

Surfactant Therapy for Respiratory Distress Syndrome in Preterm Neonates

Jornal de Pediatria

English

Respiratory Distress Syndrome in the Newborn

English

Prs48 - Cost – Effectiveness Analysis of Vilanterol/Fluticasone Furoate for Asthma Treatment in the Russian Federation

Value in Health

Occupational Health

English

Cost of Surfactant Replacement Treatment for Severe Neonatal Respiratory Distress Syndrome: A Randomised Controlled Trial.

English

Exogenous Surfactant Therapy for Pediatric Patients With Acute Respiratory Distress Syndrome

Canadian Respiratory Journal

Respiratory Medicine

English

Surfactant Medication for Acute Respiratory Distress Syndrome

Respiratory Medicine

English

Cell Therapy for the Treatment of Sepsis and Acute Respiratory Distress Syndrome

Annals of Translational Medicine

English